Viatris (VTRS) Sales of Property, Plant and Equipment (2020 - 2026)

Viatris (VTRS) Sales of Property, Plant and Equipment (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn -
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 10.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 344,333.70
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.60 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn -
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn -
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.60 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 21.20 Mn
Dec 31, 2025 21.20 Mn
Sep 30, 2025 800,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 1.60 Mn
Jun 30, 2025 1.60 Mn
Mar 31, 2025 11.30 Mn
Mar 31, 2025 11.30 Mn
Dec 31, 2024 500,000.00
Dec 31, 2024 500,000.00
Sep 30, 2024 800,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 700,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 700,000.00
Mar 31, 2024 700,000.00
Dec 31, 2023 600,000.00
Dec 31, 2023 600,000.00